These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 11747094)
1. Expression of Leu-19 (CD56, N-CAM) and nitric oxide synthase (NOS) I in denervated and reinnervated human skeletal muscle. Gosztonyi G; Naschold U; Grozdanovic Z; Stoltenburg-Didinger G; Gossrau R Microsc Res Tech; 2001 Nov; 55(3):187-97. PubMed ID: 11747094 [TBL] [Abstract][Full Text] [Related]
2. Role of nitric oxide and nitric oxide synthases in experimental models of denervation and reinnervation. Tews DS Microsc Res Tech; 2001 Nov; 55(3):181-6. PubMed ID: 11747093 [TBL] [Abstract][Full Text] [Related]
3. Expression profile of stress proteins, intermediate filaments, and adhesion molecules in experimentally denervated and reinnervated rat facial muscle. Tews DS; Goebel HH; Schneider I; Gunkel A; Stennert E; Neiss WF Exp Neurol; 1997 Jul; 146(1):125-34. PubMed ID: 9225745 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide synthase I (NOS-I) is deficient in the sarcolemma of striated muscle fibers in patients with Duchenne muscular dystrophy, suggesting an association with dystrophin. Grozdanovic Z; Gosztonyi G; Gossrau R Acta Histochem; 1996 Jan; 98(1):61-9. PubMed ID: 9054190 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of nitric oxide synthases (NOS 1-3) in human skeletal muscle following exercise countermeasure during 12 weeks of bed rest. Rudnick J; Püttmann B; Tesch PA; Alkner B; Schoser BG; Salanova M; Kirsch K; Gunga HC; Schiffl G; Lück G; Blottner D FASEB J; 2004 Aug; 18(11):1228-30. PubMed ID: 15180967 [TBL] [Abstract][Full Text] [Related]
6. Disturbed trafficking of dystrophin and associated proteins in targetoid phenomena after chronic muscle denervation. von Fellenberg A; Lin S; Burgunder JM Neuropathol Appl Neurobiol; 2004 Jun; 30(3):255-66. PubMed ID: 15175079 [TBL] [Abstract][Full Text] [Related]
7. Caveolin-3 and nitric oxide synthase I in healthy and diseased skeletal muscle. Gossrau R Acta Histochem; 1998 Feb; 100(1):99-112. PubMed ID: 9542584 [TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase (NOS) I during postnatal development in rat and mouse skeletal muscle. Christova T; Grozdanovic Z; Gossrau R Acta Histochem; 1997 Aug; 99(3):311-24. PubMed ID: 9381914 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide synthase is up-regulated in muscle fibers in muscular dystrophy. Punkt K; Schering S; Löffler S; Minin EA; Samoilova VE; Hasselblatt M; Paulus W; Müller-Werdan U; Demus U; Koehler G; Boecker W; Buchwalow IB Biochem Biophys Res Commun; 2006 Sep; 348(1):259-64. PubMed ID: 16876119 [TBL] [Abstract][Full Text] [Related]
10. Light-microscopic study of the beta 1 integrin subunit in human skeletal muscle. Heub D; Neundörfer B Clin Neuropathol; 1997; 16(6):319-27. PubMed ID: 9401799 [TBL] [Abstract][Full Text] [Related]
11. Reinnervation of murine muscle following fetal sciatic nerve transection. Mallonga RL; Ontell M J Neurobiol; 1991 Dec; 22(9):887-96. PubMed ID: 1795156 [TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthase in the heterogeneous population of intramural striated muscle fibres of the human membranous urethral sphincter. Ho KM; McMurray G; Brading AF; Noble JG; Ny L; Andersson KE J Urol; 1998 Mar; 159(3):1091-6. PubMed ID: 9474237 [TBL] [Abstract][Full Text] [Related]
13. Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion molecule recognized by monoclonal antibodies to natural killer cells. Illa I; Leon-Monzon M; Dalakas MC Ann Neurol; 1992 Jan; 31(1):46-52. PubMed ID: 1371910 [TBL] [Abstract][Full Text] [Related]
14. NO message from muscle. Grozdanovic Z Microsc Res Tech; 2001 Nov; 55(3):148-53. PubMed ID: 11747089 [TBL] [Abstract][Full Text] [Related]
15. Reinnervation-induced alterations in rat skeletal muscle. Zhou Z; Cornelius CP; Eichner M; Bornemann A Neurobiol Dis; 2006 Sep; 23(3):595-602. PubMed ID: 16877003 [TBL] [Abstract][Full Text] [Related]
16. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Tidball JG; Wehling-Henricks M Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129 [TBL] [Abstract][Full Text] [Related]
17. Vasomodulation by skeletal muscle-derived nitric oxide requires alpha-syntrophin-mediated sarcolemmal localization of neuronal Nitric oxide synthase. Thomas GD; Shaul PW; Yuhanna IS; Froehner SC; Adams ME Circ Res; 2003 Mar; 92(5):554-60. PubMed ID: 12600881 [TBL] [Abstract][Full Text] [Related]
18. Long-term delivery of FGF-6 changes the fiber type and fatigability of muscle reinnervated from embryonic neurons transplanted into adult rat peripheral nerve. Grumbles RM; Casella GT; Rudinsky MJ; Wood PM; Sesodia S; Bent M; Thomas CK J Neurosci Res; 2007 Jul; 85(9):1933-42. PubMed ID: 17492788 [TBL] [Abstract][Full Text] [Related]
20. Co-localization of nitric oxide synthase I (NOS I) and NMDA receptor subunit 1 (NMDAR-1) at the neuromuscular junction in rat and mouse skeletal muscle. Grozdanovic Z; Gossrau R Cell Tissue Res; 1998 Jan; 291(1):57-63. PubMed ID: 9394043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]